Elmiron Lawsuit Alleges Latent Retinal Damage And Impaired Vision Caused By Bladder Drug

According to allegations raised in a recently filed product liability lawsuit, a California woman suffered permanent retinal damage from Elmiron, claiming the makers of the bladder drug failed to warn consumers and the medical community about toxic side effects the medication may have on vision.

The complaint (PDF) was filed by Shirley Ruth Levy in the U.S. District Court for the District of New Jersey on August 12, indicating she was left with vision loss following four years of using Elmiron for treatment of interstitial cystitis or “painful bladder syndrome.”

The lawsuit names Azla Corporation, Johnson & Johnson, several of its subsidiaries, including Janssen Pharmaceuticals, Bayer Healthcare, and Teva Pharmaceuticals as defendants, indicating that the drug makers knew or should have known about the link between Elmiron and retinal damage for years, yet withheld warnings and information until a label update was issued in June 2020.

Elmiron (pentosan polysulfate sodium or PPS) has been marketed as safe and effective since 1996, without any indication provided until recently about the toxic effects on the retina, which may result in a condition known as pigmentary maculopathy.

Prior to the warning label update in June 2020, a series of independent studies and case reports have been published in recent years that described users of Elmiron who experienced damage to the retina, resulting in difficulty adjusting in dark light, problems reading, centralized dark spots and other complications. However, prior information was not provided to users or the medical community about the importance of monitoring for vision problems while using the medication.

“At all relevant times, Defendants have failed to adequately warn or instruct patients, the medical community, or prescribers in the United States that Elmiron causes, is linked to, and is associated with vision threatening retinal changes, including vision loss,” the lawsuit states. “Defendants failed to mention vision-threatening retinal changes or the need for opththalmological monitoring in any of the patient materials – including the Patient Education Flyer and Patient Brochure – the sources of information most likely viewed by physician and patients.”

Levy indicates she began taking Elmiron in 2013, and continued to use the medication through at least 2017. As a result of the exposure, she claims that she has suffered toxic maculopathy, retinal damage, blurred vision, distorted vision and other vision problems.

The case joins a growing number of Elmiron lawsuits now being pursued throughout the U.S. court system, each involving similar allegations that former users may have avoided permanent retinal damage if earlier warnings and information had been provided.

Since most ophthalmologists were previously unaware of the vision risks associated with Elmiron, many users were misdiagnosed with other forms of retinal disease and continued to be exposed to the medication, further worsening the damage.

As Elmiron lawyers continue to review and file claims in the coming months and years, it is expected that hundreds of similar complaints may be brought in state and federal courts nationwide.

Emerson Firm Announces Ongoing Investigation of Google Tracking Chrome User Data

Emerson Firm, PLLC announces that it is continuing its investigation into alleged Google tracking of people who used the Chrome browser’s incognito mode.

It has been alleged that Google tracks and collects consumers’ history and other Web activity no matter what safeguards consumers undertake to protect their data privacy. Even when Google users launch a Web browser with private browsing mode activated (as Google recommends to users wishing to browse the Web privately), Google nevertheless tracks the users’ browsing data and other identifying information.

These issues relate to all individuals with a Google account who accessed a website page containing Google Analytics or Ad Manager and who were (a) in private browsing mode in that device’s browser, and (b) did not log into their Google account on that device’s web browser during that session. The relevant time period is June 1, 2016 through the present.

Houston, Texas law firm Emerson Firm, PLLC represents many consumers throughout the nation. Emerson Firm, PLLC and its predecessor firms have devoted their practice to complex commercial litigation for more than thirty-eight years and have recovered more than a billion dollars for consumers in class actions throughout the United States.

If you are a person who is concerned about your privacy and used Google as described above, then this matter should concern you. Please contact us and we will discuss these matters with you and research whether your rights have been violated under your state’s laws.

IMPORTANT: Please contact us with your inquiry using the form below or via e-mail to Tanya Autry (tautry@emersonfirm.com) or John G. Emerson (jemerson@emersonfirm.com) and we will promptly get back to you to discuss your situation.

Emerson Firm Announces Ongoing Investigation of Business Interruption Claims Relating to COVID-19

Emerson Firm, PLLC announces that it is continuing its investigation into denial of valid claims by insurance companies following the filing of business interruption claims by many business owners and other business entities.

Most insurers who have issued all-risk commercial property insurance policies with business interruption coverage, are denying their obligation to pay for business income losses and other covered expenses incurred by policyholders for the physical loss and damage to their property from measures put in place by governmental entities to stop the spread of COVID-19.  We strongly believe that the denial of these claims is wrong and unjust.

If you are a person or business entity who has entered into standard all-risk commercial property insurance policy with an insurance company, where such policy provides for business income loss and extra expense coverage and does not exclude coverage for pandemics, and who has suffered losses due to measures put in place by civil authorities’ stay-at-home or shelter-in-place orders since March 15, 2020 then you may have a valid basis to pursue litigation.

Houston, Texas law firm Emerson Firm, PLLC has represented many insureds and consumers throughout the nation. Emerson Firm, PLLC and its predecessor firms have devoted their practice to complex commercial litigation for more than thirty-eight years and have recovered more than a billion dollars for insureds and consumers in class actions throughout the United States.

If you are a person or a business concerned about the denial of your business interruption claim, then please contact us and we will discuss your claim with you and advise you concerning your rights. After we speak with you, we will need your Policy, Proof of Claim, and any correspondence between you and your insurance company.

IMPORTANT:  You may contact us using the form below or by email to Tanya Autry (tautry@emersonfirm.com) or John G. Emerson (jemerson@emersonfirm.com) and we will promptly get back to you to discuss your claim.